Endothelial function in postmenopausal women with nighttime systolic hypertension

Menopause

Volumn 22, Issue 8, 2015, Pages 857-863

  Routledge, Faye S ^a,b   Hinderliter, Alan L ^c   Mcfetridge Durdle, Judith ^d   Blumenthal, James A ^b   Paine, Nicola J ^b   Sherwood, Andrew ^b  

^a EMORY UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d FLORIDA STATE UNIVERSITY   (United States)

Author keywords

Endothelial function; Flow mediated dilation; Nighttime blood pressure; Nighttime hypertension; Postmenopausal women

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ACTIMETRY; ADULT; AGED; ARTERY DIAMETER; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL FUNCTION; FEMALE; FLOW MEDIATED DILATION; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; NIGHTTIME SYSTOLIC HYPERTENSION; POSTMENOPAUSE; SYSTOLIC HYPERTENSION; BLOOD PRESSURE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CIRCADIAN RHYTHM; COMPLICATION; HYPERTENSION; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; SLEEP; SYSTOLE; VASCULAR ENDOTHELIUM;

ACTIGRAPHY; AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CIRCADIAN RHYTHM; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION; MIDDLE AGED; POSTMENOPAUSE; RISK FACTORS; SLEEP; SYSTOLE;

EID: 84938990851     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000405     Document Type: Article

References (54)

1. Go AS, Mozaffarian D, Roger VL, Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014; 129: e28-e292.
2. Kublickiene K, Svedas E, Landgren BM, Small artery endothelial dysfunction in postmenopausal women: in vitro function, morphology, and modification by estrogen and selective estrogen receptor modulators. J Clin Endocrinol Metab 2005; 90: 6113-6122.
3. Moreau KL, Hildreth KL, Meditz AL, Deane KD, Kohrt WM,. Endothelial function is impaired across the stages of the menopause transition in healthy women. J Clin Endocrinol Metab 2012; 97: 4692-4700.
4. Sherwood A, Bower JK, McFetridge-Durdle J, Blumenthal JA, Newby LK, Hinderliter AL,. Age moderates the short-Term effects of transdermal 17β-estradiol on endothelium-dependent vascular function in postmenopausal women. Arterioscler Thromb Vasc Biol 2007; 27: 1782-1787.
5. Higashi Y, Sanada M, Sasaki S, Effect of estrogen replacement therapy on endothelial function in peripheral resistance arteries in normotensive and hypertensive postmenopausal women. Hypertension 2001; 37: 651-657.
6. Hansen TW, Li Y, Boggia J, Thijs L, Richart T, Staessen JA,. Predictive role of the nighttime blood pressure. Hypertension 2011; 57: 3-10.
7. Dolan E, Stanton A, Thijs L, Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin Outcome Study. Hypertension 2005; 46: 156-161.
8. Fagard RH, Celis H, Thijs L, Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 2008; 51: 55-61.
9. Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M,. Predictors of all-cause mortality in clinical ambulatory monitoring: unique aspects of blood pressure during sleep. Hypertension 2007; 49: 1235-1241.
10. Boggia J, Thijs L, Hansen TW, Ambulatory blood pressure monitoring in 9357 subjects from 11 populations highlights missed opportunities for cardiovascular prevention in women. Hypertension 2011; 57: 397-405.
11. Hermida RC, Ayala DE, Mojon A, Fontao MJ, Chayan L, Fernandez JR,. Differences between men and women in ambulatory blood pressure thresholds for diagnosis of hypertension based on cardiovascular outcomes. Chronobiol Int 2013; 30: 221-232.
12. Verma S, Buchanan MR, Anderson TJ,. Endothelial function testing as a biomarker of vascular disease. Circulation 2003; 108: 2054-2059.
13. Harris RA, Nishiyama SK, Wray DW, Richardson RS,. Ultrasound assessment of flow-mediated dilation. Hypertension 2010; 55: 1075-1085.
14. Yeboah J, Folsom AR, Burke GL, Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the Multi-Ethnic Study of Atherosclerosis. Circulation 2009; 120: 502-509.
15. Shimbo D, Grahame-Clarke C, Miyake Y, The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis 2007; 192: 197-203.
16. Muiesan ML, Salvetti M, Paini A, Prognostic role of flow-mediated dilatation of the brachial artery in hypertensive patients. J Hypertens 2008; 26: 1612-1618.
17. Hu R, Wang WQ, Lau CP, Tse HF,. Gender differences on brachial flow-mediated dilation and carotid intima-media thickness for prediction of spontaneous cardiovascular events. Clin Cardiol 2008; 31: 525-530.
18. Rossi R, Nuzzo A, Origliani G, Modena MG,. Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women. J Am Coll Cardiol 2008; 51: 997-1002.
19. Kabutoya T, Hoshide S, Ogata Y, Eguchi K, Kario K,. Masked hypertension defined by home blood pressure monitoring is associated with impaired flow-mediated vasodilatation in patients with cardiovascular risk factors. J Clin Hypertens (Greenwich) 2013; 15: 630-636.
20. Benjamin EJ, Larson MG, Keyes MJ, Clinical correlates and heritability of flow-mediated dilation in the community-The Framingham Heart Study. Circulation 2004; 109: 613-619.
21. Raitakari OT, Juonala M, Viikari JSA, Ronnemaa T, Helenius H, Taittonen L,. Elevated blood pressure in adolescent boys predicts endothelial dysfunction-The Cardiovascular Risk in Young Finns Study. Hypertension 2006; 48: 424-430.
22. Plantinga Y, Ghiadoni L, Magagna A, Peripheral wave reflection and endothelial function in untreated essential hypertensive patients with and without the metabolic syndrome. J Hypertens 2008; 26: 1216-1222.
23. von zur Muhlen B, Millgard J, Sarabi M, Lind L,. Ambulatory blood pressure and endothelium-dependent vasodilation in hypertensive patients. Blood Press 2000; 9: 110-115.
24. Ward NC, Croft KD, Hodgson J, Rich L, Beilin LJ, Puddey IB,. Brachial artery vasomotor function is inversely associated with 24-h ambulatory blood pressure. J Hypertens 2004; 22: 967-972.
25. Higashi Y, Nakagawa K, Kimura M, Circadian variation of blood pressure and endothelial function in patients with essential hypertension: a comparison of dippers and non-dippers. J Am Coll Cardiol 2002; 40: 2039-2043.
26. Maio R, Perticone M, Sciacqua A, Oxidative stress impairs endothelial function in nondipper hypertensive patients. Cardiovasc Ther 2012; 30: 85-92.
27. Konrad T, Franke S, Schneider F, Bar F, Vetter G, Winkler K,. Nocturnal blood pressure but not insulin resistance influences endothelial function in treated hypertensive patients. J Hum Hypertens 2011; 25: 18-24.
28. Lee KW, Blann AD, Lip GY,. High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: relationship to thrombogenesis and endothelial damage/dysfunction. Am J Hypertens 2005; 18: 104-115.
29. Jones SC, Bilous M, Winship S, Finn P, Goodwin J,. Validation of the OSCAR 2 oscillometric 24-hour ambulatory blood pressure monitor according to the international protocol for the validation of blood pressure measuring devices. Blood Press Monit 2004; 9: 219-223.
30. Goodwin J, Bilous M, Winship S, Finn P, Jones SC,. Validation of the Oscar 2 oscillometric 24-h ambulatory blood pressure monitor according to the British Hypertension Society protocol. Blood Press Monit 2007; 12: 113-117.
31. Parati G, Stergiou G, O'Brien E, European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens 2014; 32: 1359-1366.
32. Pickering TG, Hall JE, Appel LJ, Recommendations for blood pressure measurement in humans and experimental animals, 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 2005; 111: 697-716.
33. O'Brien E, Asmar R, Beilin L, Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 2005; 23: 697-701.
34. Chatzistamatiou EI, Moustakas GN, Veioglanis S, Nocturnal hypertension: poor correlation with office blood pressure but strong prognostic factor for target organ damage. Hellenic J Cardiol 2012; 53: 263-272.
35. de la Sierra A, Gorostidi M, Banegas JR, Segura J, de la Cruz JJ, Ruilope LM,. Nocturnal hypertension or nondipping: which is better associated with the cardiovascular risk profile? Am J Hypertens 2014; 27: 680-687.
36. Li Y, Staessen JA, Lu L, Li LH, Wang GL, Wang JG,. Is isolated nocturnal hypertension a novel clinical entity? Findings from a Chinese population study. Hypertension 2007; 50: 333-339.
37. Ogedegbe G, Spruill TM, Sarpong DF, Correlates of isolated nocturnal hypertension and target organ damage in a population-based cohort of African Americans: the Jackson Heart Study. Am J Hypertens 2013; 26: 1011-1016.
38. Corretti MC, Anderson TJ, Benjamin EJ, Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-265.
39. Pyke KE, Dwyer EM, Tschakovsky ME,. Impact of controlling shear rate on flow-mediated dilation responses in the brachial artery of humans. J Appl Physiol 2004; 97: 499-508.
40. Inaba Y, Chen JA, Bergmann SR,. Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-Analysis. Int J Cardiovasc Imaging 2010; 26: 631-640.
41. Vita JA, Keaney JF,. Endothelial function-A barometer for cardiovascular risk? Circulation 2002; 106: 640-642.
42. Ras RT, Streppel MT, Draijer R, Zock PL,. Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-Analysis. Int J Cardiol 2013; 168: 344-351.
43. Modena MG, Bonetti L, Coppi F, Bursi F, Rossi R,. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol 2002; 40: 505-510.
44. Virdis A, Ghiadoni L, Taddei S,. Effects of antihypertensive treatment on endothelial function. Curr Hypertens Rep 2011; 13: 276-281.
45. Rossi R, Nuzzo A, Iaccarino D, Effects of antihypertensive treatment on endothelial function in postmenopausal hypertensive women. A significant role for aldosterone inhibition. J Renin Angiotensin Aldosterone Syst 2011; 12: 446-455.
46. Boggia J, Li Y, Thijs L, Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 2007; 370: 1219-1229.
47. Fan HQ, Li Y, Thijs L, Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens 2010; 28: 2036-2045.
48. Hermida RC, Ayala DE, Mojon A, Fernandez JR,. Decreasing sleep-Time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol 2011; 58: 1165-1173.
49. Hermida RC, Ayala DE, Fontao MJ, Mojon A, Alonso I, Fernandez JR,. Administration-Time-dependent effects of spirapril on ambulatory blood pressure in uncomplicated essential hypertension. Chronobiol Int 2010; 27: 560-574.
50. Hermida RC, Ayala DE, Mojon A, Fernandez JR,. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int 2010; 27: 1629-1651.
51. Hermida RC, Ayala DE, Mojon A, Fernandez JR,. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-Time regimen of hypertension medications. Chronobiol Int 2013; 30: 315-327.
52. Ayala DE, Hermida RC, Mojon A, Fernandez JR,. Cardiovascular risk of resistant hypertension: dependence on treatment-Time regimen of blood pressure-lowering medications. Chronobiol Int 2013; 30: 340-352.
53. Hermida RC, Ayala DE, Mojon A, Fernandez JR,. Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care 2011; 34: 1270-1276.
54. Hermida RC, Ayala DE, Mojon A, Fernandez JR,. Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. J Am Soc Nephrol 2011; 22: 2313-2321.